The Department of Health and Social Care seeks contractors to deliver evidence summaries across four specific areas to assess developments in the evidence base and determine the need for further assessments.
DHSC: PCP: Evidence Summaries (4 lots) FY 24/25. The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.
This contract has been divided into 4 lots. Each lot corresponds to the following lots Lot 1 Biliary atresia Lot 2 Group B strep Lot 3 Breast Risk Stratification Lot 4 Targeted Screening Contract Project Reference: C294820 Contract term: 9 months with the option to extend for up to further 2 months. Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)
The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.
The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so. To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.
Deadline for submission: 21st October 2024 at 12 noon Lot 1-Biliary atresia The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot Lot 1 Biliary atresia Lot 2-Group B strep The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 2 Group B strep Lot 3-Decision analytic model for risk stratification in breast cancer screening The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 3 Decision Analytic Model for Risk Stratification Lot 4-Targeted Screening The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 4 Targeted Screening